Literature DB >> 8927023

Nucleic acid amplification tests for tuberculosis.

.   

Abstract

Traditional methods for laboratory diagnosis of tuberculosis (TB) may require weeks, and delay can impede treatment and control efforts. Nucleic acid amplification (NAA) tests, such as polymerase chain reaction (PCR) and other methods for amplifying DNA and RNA, may facilitate rapid detection of microorganisms. An NAA test for Mycobacterium tuberculosis complex (Amplified Mycobacterium Tuberculosis Direct Test of MTD [Gen-Probe, San Diego, California]) was recently approved by the Food and Drug Administration (FDA) for use on processed clinical specimens, and others are under development. Although NAA tests have been offered by individual laboratories, approval of commercial kits may result in increased use for clinical practice and TB control. This report summarizes potential uses of NAA tests for TB diagnosis and provides interim guidelines for the use of such tests.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8927023

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  19 in total

1.  Assessment of laboratory performance of nucleic acid amplification tests for detection of Mycobacterium tuberculosis.

Authors:  John C Ridderhof; Laurina O Williams; Sue Legois; Peter A Shult; Beverly Metchock; Louise N Kubista; James H Handsfield; Ronald J Fehd; Pamela H Robinson
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 2.  Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Authors:  Claudio Piersimoni; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Unilateral Tuberculous Epididymo- Orchitis with Scrotal Fistula: a Case Report.

Authors:  Hadiseh Hosamirudsari; Farzaneh Mohammadizia
Journal:  Iran J Pathol       Date:  2015

4.  The role of polymerase chain reaction in the management of osteoarticular tuberculosis.

Authors:  Vivek Pandey; Kiran Chawla; Kiran Acharya; Sripathi Rao; Sugandhi Rao
Journal:  Int Orthop       Date:  2007-11-24       Impact factor: 3.075

5.  False-negative results obtained with the Gen-Probe Amplified Mycobacterium tuberculosis direct test caused by unrecognized inhibition of the amplification reaction.

Authors:  Ji Yeon Kim; Mary Jane Ferraro; John A Branda
Journal:  J Clin Microbiol       Date:  2009-07-08       Impact factor: 5.948

6.  Trends in Testing for Mycobacterium tuberculosis Complex From US Public Health Laboratories, 2009-2013.

Authors:  Frances Tyrrell; Cortney Stafford; Mitchell Yakrus; Monica Youngblood; Andrew Hill; Stephanie Johnston
Journal:  Public Health Rep       Date:  2016-12-12       Impact factor: 2.792

7.  Rapid and specific detection of Mycobacterium tuberculosis from acid-fast bacillus smear-positive respiratory specimens and BacT/ALERT MP culture bottles by using fluorogenic probes and real-time PCR.

Authors:  Nancimae Miller; Tim Cleary; Günter Kraus; Andrea K Young; Gina Spruill; H James Hnatyszyn
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

8.  Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.

Authors:  J Lucian Davis; L Masae Kawamura; Lelia H Chaisson; Jennifer Grinsdale; Jihane Benhammou; Christine Ho; Anna Babst; Houmpheng Banouvong; John Z Metcalfe; Mark Pandori; Philip C Hopewell; Adithya Cattamanchi
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

9.  Performance of a commercial nucleic acid amplification test with extrapulmonary specimens for the diagnosis of tuberculosis.

Authors:  C Piersimoni; S Bornigia; G Gherardi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-24       Impact factor: 3.267

Review 10.  Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.

Authors:  Philip A LoBue; Jonathan H Mermin
Journal:  Lancet Infect Dis       Date:  2017-05-08       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.